Starmet-GP
Description_Effects
Starmet-GP is a triple combination oral medication used to manage type 2 diabetes mellitus, especially in patients who are unable to achieve adequate blood sugar control with single or dual therapy. It contains Glimepiride, Metformin, and Pioglitazone — three well-established antidiabetic agents that work through complementary mechanisms to improve glycemic control. Glimepiride is a sulfonylurea that stimulates the pancreas to release more insulin, thereby lowering blood glucose levels. Metformin, a biguanide, reduces glucose production in the liver, slows glucose absorption from the gut, and enhances insulin sensitivity in peripheral tissues. Pioglitazone, a thiazolidinedione, further increases the body’s sensitivity to insulin, helping cells use glucose more effectively. This multi-pronged approach helps control both fasting and postprandial (after meal) blood sugar levels, making Starmet-GP highly effective in managing long-term blood sugar levels and reducing the risk of diabetes-related complications. Starmet-GP is usually taken once or twice daily with meals to minimize gastrointestinal side effects. Common side effects may include hypoglycemia, weight gain, stomach upset, or fluid retention. Regular monitoring of blood glucose, kidney function, and liver enzymes is advised during treatment. Always take this medication as prescribed by your doctor to ensure safe and effective diabetes management.
